Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRNA Moderna, Inc.

休市中 07-10 16:00:00 EDT

68.27

-8.29

-10.83%

盘后68.30

+0.03+0.04%

19:59 EDT

最高76.72	最低67.31	成交量917.69万
今开76.72	昨收76.56	日振幅12.29%
总市值269.63亿	流通市值249.59亿	总股本3.95亿
成交额6.36亿	换手率2.51%	流通股本3.66亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRNA","market":"US","secType":"STK","nameCN":"Moderna, Inc.","latestPrice":68.27,"timestamp":1783713600000,"preClose":76.56,"halted":0,"volume":9176930,"hourTrading":{"tag":"盘后","latestPrice":68.3,"preClose":68.27,"latestTime":"19:59 EDT","volume":60367,"amount":4123300.3408,"timestamp":1783727982479,"change":0.03,"changeRate":0.000439,"amplitude":0.00851},"delay":0,"changeRate":-0.10828108672936267,"floatShares":365596516,"shares":394939400,"eps":-8.14,"marketStatus":"休市中","change":-8.29,"latestTime":"07-10 16:00:00 EDT","open":76.722,"high":76.722,"low":67.31,"amount":635757888.2312,"amplitude":0.122936,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-8.14,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1783929600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1544158800000,"exchange":"NASDAQ","adjPreClose":76.56,"preHourTrading":{"tag":"盘前","latestPrice":76.51,"preClose":76.56,"latestTime":"09:29 EDT","volume":30194,"amount":2341715.59804,"timestamp":1783690199999,"change":-0.05,"changeRate":-0.000653,"amplitude":0.025731},"postHourTrading":{"tag":"盘后","latestPrice":68.3,"preClose":68.27,"latestTime":"19:59 EDT","volume":60367,"amount":4123300.3408,"timestamp":1783727982479,"change":0.03,"changeRate":0.000439,"amplitude":0.00851},"volumeRatio":0.8980454010804602,"optionData":{"bulkOrders":[{"symbol":"MRNA","call":true,"expireDate":1783656000000,"strike":"85.0","timestamp":1783691908510,"price":0.03,"volume":6100,"amount":18300,"type":"-"},{"symbol":"MRNA","call":true,"expireDate":1783656000000,"strike":"80.0","timestamp":1783691908510,"price":0.06,"volume":6100,"amount":36600,"type":"-"}]},"impliedVol":0.9342,"impliedVolPercentile":0.9243},"requestUrl":"/m/hq/s/MRNA/wiki","defaultTab":"wiki","newsList":[{"id":"2650155620","title":"1个月上涨25%后，美国生物医药板块周五重挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2650155620","media":"华尔街见闻","labels":["movement"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650155620?lang=zh_cn&edition=full","pubTime":"2026-07-11 15:10","pubTimestamp":1783753844,"startTime":"0","endTime":"0","summary":"美股生物医药板块因集中获利了结引发急跌，高贝塔代表性ETF（XBI）单日大跌4%。Moderna、ImmunityBio等年内暴涨股在无基本面利空的情况下回撤8%~11%，资金呈现从高风险小盘股向强防御大市值药企跨板块结构性轮动。","market":"sg","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3776698","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"1个月上涨25%后，美国生物医药板块周五重挫","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","IBRX","MRNA","161726","MRNY","ELIL","LLYZ","MRNX","BK4588","LLII","BK4581","BK4585","LLY","ELIS","LLYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650132294","title":"Moderna(MRNA.O)收跌11%，创下自2025年5月以来最大跌幅。","url":"https://stock-news.laohu8.com/highlight/detail?id=2650132294","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650132294?lang=zh_cn&edition=full","pubTime":"2026-07-11 04:03","pubTimestamp":1783713806,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["MRNY","LGHT","MRNX","BK4548","BK4585","BK4501","BK4532","WDNA","BK4533","IDNA","BK4139","BK4551","BK4568","GNOM","MRNA","BK4534","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164757818","title":"异动解读 | Moderna盘中大跌7.67%，机构看空叠加获利了结压力持续释放","url":"https://stock-news.laohu8.com/highlight/detail?id=1164757818","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164757818?lang=zh_cn&edition=full","pubTime":"2026-07-10 21:45","pubTimestamp":1783691114,"startTime":"0","endTime":"0","summary":"Moderna, Inc.今日盘中股价大跌7.67%，引起了市场的广泛关注。消息面上，美国银行此前虽然将Moderna目标价从34美元上调至38美元，但仍维持“跑输大盘”评级，该目标价较当前股价存在显著折价。此外，Moderna此前因流感疫苗mRNA-1010获FDA咨询委员会一致支持等利好，股价已累计大幅上涨，相关利好已被市场充分交易。在连续大涨后，机构维持明确看空立场，叠加投资者获利了结压力持续释放，共同导致了股价的延续回调。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179045503","title":"异动解读｜Moderna盘中下跌5.51%，美国银行维持看空评级叠加获利了结压力延续回调","url":"https://stock-news.laohu8.com/highlight/detail?id=1179045503","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179045503?lang=zh_cn&edition=full","pubTime":"2026-07-10 21:42","pubTimestamp":1783690928,"startTime":"0","endTime":"0","summary":"7月10日，Moderna盘中下跌5.51%，报70.95美元/股，成交额8380.47万美元。此外，美国银行指出Moderna即将于7月31日发布的二季度业绩可能面临更严格的市场审查。Moderna此前因流感疫苗mRNA-1010获FDA咨询委员会9:0一致支持等利好累计大涨逾18%，相关利好已被充分交易。在连续大涨后，机构维持明确看空立场叠加获利了结压力持续释放，股价延续回调态势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199977227","title":"异动解读 | Moderna盘中大跌5.26%，美国银行维持看空评级叠加获利了结压力","url":"https://stock-news.laohu8.com/highlight/detail?id=1199977227","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199977227?lang=zh_cn&edition=full","pubTime":"2026-07-08 21:40","pubTimestamp":1783518032,"startTime":"0","endTime":"0","summary":"Moderna（MRNA）今日盘中股价大跌5.26%，引起了市场关注。消息面上，美国银行此前虽将Moderna目标价从34美元上调至38美元，但维持了“跑输大盘”的评级，且该目标价较当前股价仍折价超过50%，与市场普遍预期存在显著差距。此外，Moderna此前一周因流感疫苗mRNA-1010获得FDA咨询委员会一致支持等利好，股价已累计上涨超过18%，相关利好已被市场充分消化。在连续大幅上涨后，机构明确的看空立场，加上投资者获利了结的压力持续释放，共同导致了股价在盘中延续回调态势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137177163","title":"异动解读｜Moderna盘中下跌5.04%，美国银行维持看空评级叠加获利了结压力延续回调","url":"https://stock-news.laohu8.com/highlight/detail?id=1137177163","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137177163?lang=zh_cn&edition=full","pubTime":"2026-07-08 21:39","pubTimestamp":1783517960,"startTime":"0","endTime":"0","summary":"7月8日，Moderna盘中下跌5.04%，报76.26美元/股，成交额5888.19万美元。消息面上，美国银行此前将Moderna目标价从34美元上调至38美元，但维持\"跑输大盘\"评级，该目标价较当前股价仍折价逾50%，与FactSet统计的市场一致目标价50.53美元亦存在显著差距。Moderna此前一周因流感疫苗mRNA-1010获FDA咨询委员会9:0一致支持等利好累计大涨逾18%，相关利好已被充分交易。在连续大涨后，机构维持明确看空立场叠加获利了结压力持续释放，股价延续回调态势。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107527550","title":"异动解读 | Moderna盘中大跌5.06%，美国银行维持看空评级及获利了结压力致股价回调","url":"https://stock-news.laohu8.com/highlight/detail?id=1107527550","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107527550?lang=zh_cn&edition=full","pubTime":"2026-07-07 22:58","pubTimestamp":1783436313,"startTime":"0","endTime":"0","summary":"Moderna, Inc.  今日盘中股价大跌5.06%，引发了市场关注。消息面上，美国银行将Moderna目标价从34美元上调至38美元，但维持“跑输大盘”评级，该目标价较当前股价折价逾50%，与市场一致目标价亦存在显著差距。同时，Moderna此前一周因流感疫苗mRNA-1010获FDA咨询委员会一致支持等利好，股价已累计大涨逾18%，相关利好已被充分交易。在连续大涨后，机构维持明确看空立场叠加获利了结压力，成为股价回调的直接触发因素。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130086035","title":"异动解读｜Moderna盘中下跌5.04%，美国银行维持跑输大盘评级目标价远低于现价","url":"https://stock-news.laohu8.com/highlight/detail?id=1130086035","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130086035?lang=zh_cn&edition=full","pubTime":"2026-07-07 22:57","pubTimestamp":1783436242,"startTime":"0","endTime":"0","summary":"7月7日，Moderna盘中下跌5.04%，报79.38美元/股，成交额2.14亿美元。消息面上，美国银行将Moderna目标价从34美元上调至38美元，但维持\"跑输大盘\"评级，该目标价较当前股价折价逾50%，与FactSet统计的市场一致目标价50.53美元亦存在显著差距。值得注意的是，Moderna此前一周累计大涨逾18%，流感疫苗mRNA-1010获FDA咨询委员会9:0一致支持、管线多重催化等利好已被充分交易。在连续大涨后，机构维持明确看空立场叠加获利了结压力，成为股价回调的直接触发因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107109253","title":"异动解读 | Moderna盘中大涨5.13%，流感疫苗获批预期与管线多重催化推动股价上扬","url":"https://stock-news.laohu8.com/highlight/detail?id=1107109253","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107109253?lang=zh_cn&edition=full","pubTime":"2026-07-06 23:35","pubTimestamp":1783352108,"startTime":"0","endTime":"0","summary":"Moderna, Inc.今日盘中大涨5.13%，引起了市场的广泛关注。消息面上，公司季节性流感疫苗候选产品mRNA-1010此前获得美国食品药品监督管理局咨询委员会的一致支持，市场对其最终获批的预期持续升温。此外，Arete于近期将公司目标价大幅上调至433美元，远超市场一致预期。公司在其科学日活动上首次披露了针对自身免疫疾病的体内CAR-T项目mRNA-6007，并计划于明年进入临床阶段。同时，公司展示了包括肿瘤疫苗和AI研发平台在内的多条管线进展，市场对其向平台型生物药企进行估值切换的预期正在持续发酵。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110574655","title":"异动解读｜Moderna盘中上涨5.13%，流感疫苗获批预期与管线多重催化延续涨势","url":"https://stock-news.laohu8.com/highlight/detail?id=1110574655","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110574655?lang=zh_cn&edition=full","pubTime":"2026-07-06 23:32","pubTimestamp":1783351964,"startTime":"0","endTime":"0","summary":"7月6日，Moderna盘中上涨5.13%，报83.85美元/股，成交额3.48亿美元。消息面上，公司季节性流感疫苗候选产品mRNA-1010此前获FDA咨询委员会9票赞成、0票反对的一致支持，最终审批结果预计8月5日公布，市场对获批预期持续升温。此外，Arete于6月29日将目标价从185美元大幅上调至433美元，远超市场一致目标价319.37美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124915846","title":"一周美股牛榜｜ AXON大涨28%，MRNA上涨18%；PLTR反弹14%，终结周线跌势","url":"https://stock-news.laohu8.com/highlight/detail?id=1124915846","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124915846?lang=zh_cn&edition=full","pubTime":"2026-07-06 10:56","pubTimestamp":1783306600,"startTime":"0","endTime":"0","summary":"Moderna 股价大涨，市场对流感疫苗获批预期持续升温 $Moderna, Inc.$上周上涨18.57%。此外，公司季节性流感疫苗候选产品mRNA-1010获得美国食品药品监督管理局疫苗及相关生物制品咨询委员会9票赞成、0票反对的一致支持，最终监管审批结果预计将于8月5日公布。此前，Arete已于6月29日将目标价从185美元大幅上调至433美元，涨幅超过130%，远高于FactSet统计的市场一致目标价319.37美元。","market":"us","thumbnail":"https://community-static.tradeup.com/news/22da2c534d3aec2c1f8e84961ecdfcd9","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/22da2c534d3aec2c1f8e84961ecdfcd9"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOOD","PANW","MRNA","AXON","PLTG","ROBN","PLTI","PLTW","MRNY","VEEV","HODU","HOOX","PLTU","MRNX","ORLY","HOYY","PLOO","AXUP","HOOZ","HOOY","FOXA","HOII","PLYY","HOOW","PLTR","PANG","PLTA","GPC","PTIR","PLTZ","PLTY","HOOG","PALD","HOOI","PALU","PLTD","APD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122245921","title":"异动解读 | Moderna盘中大涨6.94%，科学日管线催化与流感疫苗获批预期推动股价走高","url":"https://stock-news.laohu8.com/highlight/detail?id=1122245921","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122245921?lang=zh_cn&edition=full","pubTime":"2026-07-02 21:51","pubTimestamp":1783000292,"startTime":"0","endTime":"0","summary":"Moderna, Inc.今日盘中大涨6.94%，引起了市场广泛关注。6月25日，Moderna举办了科学日活动，首次披露了体内CAR-T项目mRNA-6007，计划针对B细胞介导的自身免疫疾病于明年进入临床，同时展示了肿瘤疫苗、癌症预防疫苗及AI研发平台等多条管线，市场对其向平台型生物药企估值切换的预期持续升温。受上述积极进展鼓舞，多家投行上调了Moderna的目标价，例如Piper Sandler将其目标价上调至77美元，杰富瑞上调至53美元，这进一步增强了投资者的信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130800385","title":"异动解读｜Moderna盘中上涨5.72%，科学日管线催化与流感疫苗获批预期持续发酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1130800385","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130800385?lang=zh_cn&edition=full","pubTime":"2026-07-02 21:48","pubTimestamp":1783000094,"startTime":"0","endTime":"0","summary":"7月2日，Moderna盘中上涨5.72%，报77.405美元/股，成交额1.2亿美元。6月25日Moderna举办科学日活动，首次披露体内CAR-T项目mRNA-6007，计划针对B细胞介导的自身免疫疾病于明年进入临床，同时展示肿瘤疫苗、癌症预防疫苗及AI研发平台等多条管线，市场对其向平台型生物药企估值切换的预期持续升温。此外，其季节性流感疫苗mRNA-1010此前获FDA咨询委员会9-0一致支持，最终审批决定预计8月初做出。受上述进展鼓舞，Piper Sandler将目标价上调至77美元，杰富瑞上调至53美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126092123","title":"异动解读 | Moderna盘中大涨5.33%，科学日新管线与流感疫苗进展提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1126092123","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126092123?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:47","pubTimestamp":1782917242,"startTime":"0","endTime":"0","summary":"Moderna, Inc.  今日盘中大涨5.33%，股价异动显著。消息面上，公司近期多重利好持续发酵。首先，Moderna在近期举办的科学日活动上首次披露了针对B细胞介导自身免疫疾病的体内CAR-T项目mRNA-6007，并计划于明年进入临床。此外，其季节性流感疫苗mRNA-1010获得了美国食品药品监督管理局咨询委员会的一致支持，最终审批决定预计将于近期做出，这为产品上市带来了积极预期。受这些进展鼓舞，多家机构上调了公司目标价。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115386268","title":"异动解读｜Moderna盘中上涨5.21%，科学日催化与流感疫苗获批预期延续推动","url":"https://stock-news.laohu8.com/highlight/detail?id=1115386268","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115386268?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:45","pubTimestamp":1782917110,"startTime":"0","endTime":"0","summary":"7月1日，Moderna盘中上涨5.21%，报72.26美元/股，成交额1.34亿美元。消息面上，公司近期多重利好持续发酵。6月25日Moderna举办科学日活动，首次披露体内CAR-T项目mRNA-6007，计划针对B细胞介导的自身免疫疾病于明年进入临床，同时展示了肿瘤疫苗、癌症预防疫苗及AI研发平台等多条管线布局，市场对其从单一疫苗公司向平台型生物药企的估值切换预期升温。多家机构随之上调目标价，Piper Sandler将目标价提升至77美元，杰富瑞上调至53美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101034383","title":"莫德纳股价因自身免疫性疾病新研究计划而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1101034383","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101034383?lang=zh_cn&edition=full","pubTime":"2026-06-27 02:30","pubTimestamp":1782498636,"startTime":"0","endTime":"0","summary":"这家因信使RNA新冠疫苗而闻名的生物技术公司，正利用类似技术开发针对皮肤癌、肺癌及其他类型肿瘤的癌症疗法。在周四与分析师举行的会议上，公司高管透露了这一信息。此外，一项潜在的新型自身免疫性疾病疗法，采用了基于细胞的机制，即CAR-T技术。\n莫德纳股价周五上涨超过10%。此前，该公司公布了一项针对自身免疫性疾病的新治疗计划，并概述了多项实验性药物项目，这些项目有望在未来几年帮助其业务多元化，不再局限于新冠疫苗领域。\n今年以来，随着市场对该公司新药获批前景的乐观情绪升温，莫德纳股价已累计上涨超过一倍。这其中包括其与默克公司共同开发的一款实验性黑色素瘤疫苗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","BK4551","BK4139","BK4548","BK4568","BK4585","BK4532","MRNA","MRNX","BK4533","MRNY","BK4534","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140503238","title":"异动解读｜Moderna盘中上涨5.23%，多家投行同日上调目标价提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1140503238","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140503238?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:24","pubTimestamp":1782483897,"startTime":"0","endTime":"0","summary":"6月26日，Moderna盘中上涨5.23%，报66.485美元/股，成交额1.78亿美元。消息面上，当日多家投行集中上调Moderna目标价：Piper Sandler将目标价从69美元上调至77美元，维持增持评级；杰富瑞将目标价从45美元上调至53美元，维持持有评级。多家机构同日发出积极信号，显著提振了投资者信心。基本面方面，公司近期利好持续释放。此外，公司已完成组织架构调整并任命新首席商务官，为未来多款新疫苗上市做准备。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136319745","title":"异动解读 | 杰富瑞上调目标价，Moderna盘中大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136319745","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136319745?lang=zh_cn&edition=full","pubTime":"2026-06-26 21:45","pubTimestamp":1782481519,"startTime":"0","endTime":"0","summary":"莫德纳公司（Moderna, Inc.）今日盘中股价大幅上涨5.17%，引起了市场的关注。消息面上，杰富瑞（Jefferies）将莫德纳的目标价从45美元上调至53美元，这一积极的分析师行动通常被视为对公司未来前景的乐观信号，从而提振了投资者信心并推动了股价的上涨。该研究报告发布于周五，其中涵盖了多家美国公司的评级和目标价调整，莫德纳是其中之一。分析师上调目标价的行为，往往反映了对公司基本面、增长潜力或行业趋势的重新评估。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182524368","title":"异动解读 | Moderna盘中大涨7.74%，技术性反弹叠加流感疫苗获批预期支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=1182524368","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182524368?lang=zh_cn&edition=full","pubTime":"2026-06-23 22:56","pubTimestamp":1782226607,"startTime":"0","endTime":"0","summary":"Moderna, Inc.（MRNA）今日盘中大涨7.74%，引起了市场的广泛关注。消息面上，该股前一交易日因短期获利回吐压力出现急跌，今日买盘回补推动技术性反弹。同时，公司基本面利好仍在，其mRNA流感疫苗mFlusiva获得了美国食品药品监督管理局（FDA）顾问委员会的9-0全票推荐批准。数据显示，该疫苗在50岁以上人群中可引发强烈的免疫反应，若最终获批，将成为美国首款mRNA季节性流感疫苗。FDA的最终审批决定预计在8月初做出。此外，公司近期已完成组织架构调整，任命了Ester Banque为首席商务官，为未来两年内可能多达三款新疫苗的上市做准备。这些积极因素共同支撑了股价的强劲表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166274767","title":"异动解读｜Moderna盘中上涨5.45%，前一交易日急跌后技术性反弹叠加流感疫苗获批预期支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=1166274767","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166274767?lang=zh_cn&edition=full","pubTime":"2026-06-23 22:55","pubTimestamp":1782226546,"startTime":"0","endTime":"0","summary":"6月23日，Moderna盘中上涨5.45%，报62.745美元/股，成交额1.57亿美元。消息面上，该股前一交易日因短期获利回吐压力大跌逾5%，但基本面利好仍在。此前公司mRNA流感疫苗mFlusiva获FDA顾问委员会9-0全票推荐批准，数据显示该疫苗在50岁以上人群中可引发强烈免疫反应，若获批将成为美国首款mRNA季节性流感疫苗。FDA最终审批决定预计8月初做出。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.modernatx.com;www.investors.modernatx.com","stockEarnings":[{"period":"1week","weight":-0.1441},{"period":"1month","weight":0.4845},{"period":"3month","weight":0.3397},{"period":"6month","weight":0.9904},{"period":"1year","weight":0.9915},{"period":"ytd","weight":1.315}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1111},{"period":"6month","weight":0.0877},{"period":"1year","weight":0.2063},{"period":"ytd","weight":0.1071}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Moderna, Inc.于2016年7月22日根据特拉华州法律注册成立。该公司是信使核糖核酸（信使核糖核酸）医学领域的领导者。通过在科学、技术和健康的交叉领域工作十多年，该公司以前所未有的速度和效率开发出药物，包括最早和最有效的新冠疫苗之一。该公司的mRNA平台已使传染病、免疫肿瘤学、罕见病和自身免疫性疾病的疗法和疫苗的开发成为可能。凭借独特的文化和由Moderna价值观和思维模式驱动的全球化团队，以负责任的方式改变人类健康的未来，该公司努力通过mRNA药物向人们传递尽可能大的影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.112326},{"month":2,"riseRate":0.375,"avgChangeRate":0.016129},{"month":3,"riseRate":0.5,"avgChangeRate":0.01856},{"month":4,"riseRate":0.625,"avgChangeRate":0.096502},{"month":5,"riseRate":0.625,"avgChangeRate":0.057817},{"month":6,"riseRate":0.5,"avgChangeRate":0.038602},{"month":7,"riseRate":0.625,"avgChangeRate":0.090119},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.089569},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.018964},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.032236},{"month":11,"riseRate":0.714286,"avgChangeRate":0.206001},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.033274}],"exchange":"NASDAQ","name":"Moderna, Inc.","nameEN":"Moderna, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Moderna, Inc.,MRNA,Moderna, Inc.股票,Moderna, Inc.股票老虎,Moderna, Inc.股票老虎国际,Moderna, Inc.行情,Moderna, Inc.股票行情,Moderna, Inc.股价,Moderna, Inc.股市,Moderna, Inc.股票价格,Moderna, Inc.股票交易,Moderna, Inc.股票购买,Moderna, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}